Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Nutex Health (NUTX) Research & Development: 2018-2022

Historic Research & Development for Nutex Health (NUTX) over the last 5 years, with Q1 2022 value amounting to $73750.0.

  • Nutex Health's Research & Development fell 387.12% to $73750.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $295547.0, marking a year-over-year increase of 605.63%. This contributed to the annual value of $285880.0 for FY2021, which is 4869.87% down from last year.
  • Per Nutex Health's latest filing, its Research & Development stood at $73750.0 for Q1 2022, which was down 387.12% from $77265.0 recorded in Q4 2021.
  • Nutex Health's 5-year Research & Development high stood at $604000.0 for Q4 2018, and its period low was $54296.0 during Q4 2020.
  • Its 5-year average for Research & Development is $163499.3, with a median of $92513.0 in 2019.
  • Within the past 5 years, the most significant YoY rise in Nutex Health's Research & Development was 4230.33% (2021), while the steepest drop was 8102.53% (2021).
  • Nutex Health's Research & Development (Quarter) stood at $604000.0 in 2018, then tumbled by 67.45% to $196632.0 in 2019, then tumbled by 72.39% to $54296.0 in 2020, then soared by 42.3% to $77265.0 in 2021, then decreased by 4.55% to $73750.0 in 2022.
  • Its Research & Development stands at $73750.0 for Q1 2022, versus $77265.0 for Q4 2021 and $72266.0 for Q3 2021.